A M Moses, M Miller. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acetaminophen/adverse effectsAmitriptyline/adverse effectsAnimalsAnuraBody Fluids/metabolismCarbamazepine/adverse effectsChlorpropamide/therapeutic useClofibrate/adverse effectsCyclophosphamide/adverse effectsDiabetes Insipidus/drug therapyDiabetes Insipidus/physiopathologyDiabetes Mellitus/drug therapyDiazoxide/adverse effectsDrug-Related Side Effects and Adverse ReactionsHumansHypoglycemic Agents/adverse effectsHyponatremia/chemically inducedHyponatremia/metabolismKidney/physiologyRatsSodium/metabolismSulfonylurea Compounds/adverse effectsSulfonylurea Compounds/therapeutic useTolbutamide/adverse effectsTolbutamide/therapeutic useUrinary Bladder/physiologyVasopressins/metabolismVasopressins/physiologyVincristine/adverse effectsWater Intoxication/metabolismWater-Electrolyte Balance
Substances: See more » Hypoglycemic AgentsSulfonylurea CompoundsVasopressinsAmitriptylineCarbamazepineAcetaminophenVincristineCyclophosphamideTolbutamideSodiumClofibrateDiazoxideChlorpropamide
Year: 1974 PMID: 4607502 DOI: 10.1056/NEJM197412052912307
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245